image credit: Pixabay

Nexus Pharmaceuticals Announces Verbal to Occupy Authorization

March 26, 2021

Via: BioSpace

Lincolnshire, Illinois—Nexus Pharmaceuticals, Inc. is pleased to announce that it has received authorization to occupy its new pharmaceutical manufacturing facility from the Village of Pleasant Prairie, Wisconsin.

Nexus Pharmaceuticals, which specializes in developing innovative processes to manufacture specialty and generic injectables drugs, first announced its plans in 2019 to build Project Tomorrow, a state-of-the-art sterile injectable manufacturing facility to support the production and supply of injectable drugs in various therapeutic areas including anesthesiology, oncology, cardiology, and neurology.

Read More on BioSpace